\-\ Texto\\:\\ \ \(0\)\
\-\ grouped\\ papules\\ with\\ very\\ mild\\ erythema\\.\\ \\ no\\ surface\\ change\\.\\ \\ slightly\\ raised\\ with\\ very\\ minimal\\ central\\ indentation\\.\\ no\\ bleeding\\ or\\ discharge\\.\ \(0\)\
\-\ treatment\\ recommendations\\ include\\ a\\ course\\ of\\ potent\\ topical\\ steroid\\,\\ such\\ as\\ clobetasol\\ or\\ fluocinonide\\ ointment\\ for\\ several\\ weeks\\.\ \(0\)\
\-\ biopsy\\ would\\ be\\ reasonable\\,\\ if\\ available\\.\\ \\ \ \(0\)\
\-\ lichen\\ planus\\ has\\ been\\ associated\\ with\\ hepatitis\\ c\\ so\\ screening\\ is\\ appropriate\\.\ \(0\)\
\-\ grouped\\ papules\\ with\\ very\\ mild\\ erythema\\.\ \(0\)\
\-\ lichen\\ planus\ \(2\)\
\-\ \\â\\€\\¢\\ athropod\\ bite\ \(0\)\
\-\ \\â\\€\\¢\\ eczema\ \(0\)\
\-\ \\â\\€\\¢\\ granuloma\\ annulare\ \(0\)\
\-\ 44\\ y\\.o\\.\\ male\\ with\\ a\\ past\\ medical\\ history\\ of\\ vitiligo\\.\\ developed\\ a\\ rash\\ on\\ the\\ volar\\-palmar\\ aspect\\ of\\ right\\ wrist\\ approximately\\ 8\\ weeks\\ ago\\.\\ no\\ known\\ exposures\\.\ \(0\)\
\-\ non\\-pruritic\\.\\ slightly\\ raised\\ with\\ very\\ minimal\\ central\\ indentation\\.\\ no\\ bleeding\\ or\\ discharge\\.\\ not\\ course\\ or\\ scab\\-like\\.\\ \ \(0\)\
\-\ non\\-responsive\\ to\\ hydrocortisone\\ topical\\ \\(1\\%\\ or\\ 2\\%\\)\\.\\ no\\ new\\ contact\\ with\\ pets\\/animals\\.\\ no\\ other\\ past\\ medical\\ history\\.\\ nkda\\.\\ social\\ history\\ is\\ significant\\ for\\ \\ dipping\\.\\ constitution\\ symptoms\\:\\ negative\\.\ \(0\)\
\-\ the\\ most\\ likely\\ diagnosis\\ is\\ lichen\\ planus\\.\\ \\ this\\ case\\ has\\ many\\ of\\ the\\ hallmark\\ signs\\,\\ including\\ \\"purple\\,\\ polygonal\\,\\ planar\\,\\ papules\\"\\.\\ \\ typically\\,\\ lichen\\ planus\\ is\\ also\\ pruritic\\,\\ but\\ the\\ 5th\\ \\"p\\"\\ was\\ not\\ noted\\ by\\ this\\ patient\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ lichen\\:\\ 0\\.1476794771528464\ \(0\)\
\-\ planus\\:\\ 0\\.11668405729396596\ \(0\)\
\-\ papules\\:\\ 0\\.07578302571743203\ \(0\)\
\-\ grouped\\:\\ 0\\.07015369213907625\ \(0\)\
\-\ very\\:\\ 0\\.05639610215376598\ \(0\)\
\-\ indentation\\:\\ 0\\.05493572456115197\ \(0\)\
\-\ topical\\:\\ 0\\.05290714682193188\ \(0\)\
\-\ raised\\:\\ 0\\.0495292963089093\ \(0\)\
\-\ fluocinonide\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ athropod\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ annulare\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ vitiligo\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ volar\\-palmar\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ non\\-pruritic\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ scab\\-like\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ pets\\/animals\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ dipping\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ constitution\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ erythema\\:\\ 0\\.03818543551932035\ \(0\)\
\-\ discharge\\:\\ 0\\.03766081445004174\ \(0\)\
\-\ potent\\:\\ 0\\.0369198692882116\ \(0\)\
\-\ clobetasol\\:\\ 0\\.03507684606953813\ \(0\)\
\-\ purple\\:\\ 0\\.03507684606953813\ \(0\)\
\-\ polygonal\\:\\ 0\\.03507684606953813\ \(0\)\
\-\ non\\-responsive\\:\\ 0\\.0337692002856664\ \(0\)\
\-\ hydrocortisone\\:\\ 0\\.0337692002856664\ \(0\)\
\-\ bleeding\\:\\ 0\\.033723390455144706\ \(0\)\
\-\ eczema\\:\\ 0\\.03192617706699292\ \(0\)\
\-\ exposures\\:\\ 0\\.03192617706699292\ \(0\)\
\-\ slightly\\:\\ 0\\.031402056893246114\ \(0\)\
\-\ ointment\\:\\ 0\\.03061853128312119\ \(0\)\
\-\ bite\\:\\ 0\\.03061853128312119\ \(0\)\
\-\ minimal\\:\\ 0\\.03058618154909816\ \(0\)\
\-\ hallmark\\:\\ 0\\.029604242413511145\ \(0\)\
\-\ course\\:\\ 0\\.0293139222132331\ \(0\)\
\-\ pruritic\\:\\ 0\\.02917101432349149\ \(0\)\
\-\ nkda\\:\\ 0\\.027467862280575985\ \(0\)\
\-\ recommendations\\:\\ 0\\.02581829185471522\ \(0\)\
\-\ reasonable\\:\\ 0\\.025624839061902507\ \(0\)\
\-\ central\\:\\ 0\\.025560285062363262\ \(0\)\
\-\ planar\\:\\ 0\\.025261008572477345\ \(0\)\
\-\ past\\:\\ 0\\.0246836315631494\ \(0\)\
\-\ contact\\:\\ 0\\.0240416268152288\ \(0\)\
\-\ medical\\:\\ 0\\.023902816364236402\ \(0\)\
\-\ rash\\:\\ 0\\.02365727505146488\ \(0\)\
\-\ no\\:\\ 0\\.023466658655558234\ \(0\)\
\-\ or\\:\\ 0\\.022761880658266082\ \(0\)\
\-\ social\\:\\ 0\\.022667622852170013\ \(0\)\
\-\ hepatitis\\:\\ 0\\.022288615538810688\ \(0\)\
\-\ weeks\\:\\ 0\\.022047979608192256\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.021368377521762107\ \(0\)\
\-\ steroid\\:\\ 0\\.020506606048919674\ \(0\)\
\-\ mild\\:\\ 0\\.020456849581192153\ \(0\)\
\-\ 5th\\:\\ 0\\.019984899164408636\ \(0\)\
\-\ 44\\:\\ 0\\.01993046193237811\ \(0\)\
\-\ p\\:\\ 0\\.01993046193237811\ \(0\)\
\-\ granuloma\\:\\ 0\\.019092717759660174\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.019092136705743792\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.018724995472565845\ \(0\)\
\-\ c\\:\\ 0\\.018463310149364243\ \(0\)\
\-\ appropriate\\:\\ 0\\.018309212187202054\ \(0\)\
\-\ \\%\\:\\ 0\\.018121100303145524\ \(0\)\
\-\ wrist\\:\\ 0\\.017945381697776888\ \(0\)\
\-\ so\\:\\ 0\\.017673930630951334\ \(0\)\
\-\ surface\\:\\ 0\\.0171458786683966\ \(0\)\
\-\ screening\\:\\ 0\\.016568338313310664\ \(0\)\
\-\ history\\:\\ 0\\.016093834605096592\ \(0\)\
\-\ many\\:\\ 0\\.015964606890488283\ \(0\)\
\-\ change\\:\\ 0\\.01513964313852656\ \(0\)\
\-\ developed\\:\\ 0\\.014954843112885065\ \(0\)\
\-\ has\\:\\ 0\\.01458818154994798\ \(0\)\
\-\ 8\\:\\ 0\\.014523261628406128\ \(0\)\
\-\ ago\\:\\ 0\\.01445785827635113\ \(0\)\
\-\ including\\:\\ 0\\.01402463018633147\ \(0\)\
\-\ would\\:\\ 0\\.013822576720100408\ \(0\)\
\-\ biopsy\\:\\ 0\\.013780423825621639\ \(0\)\
\-\ typically\\:\\ 0\\.013711026225027146\ \(0\)\
\-\ signs\\:\\ 0\\.01366989060902752\ \(0\)\
\-\ new\\:\\ 0\\.013535399894547991\ \(0\)\
\-\ available\\:\\ 0\\.013057813858362714\ \(0\)\
\-\ several\\:\\ 0\\.012486785616919942\ \(0\)\
\-\ known\\:\\ 0\\.012291141293017362\ \(0\)\
\-\ aspect\\:\\ 0\\.012201326974924352\ \(0\)\
\-\ such\\:\\ 0\\.012142421772003873\ \(0\)\
\-\ approximately\\:\\ 0\\.012017353757070831\ \(0\)\
\-\ negative\\:\\ 0\\.01160054618806761\ \(0\)\
\-\ not\\:\\ 0\\.011225624288563048\ \(0\)\
\-\ y\\.o\\:\\ 0\\.011210815602666818\ \(0\)\
\-\ likely\\:\\ 0\\.010955863481525711\ \(0\)\
\-\ include\\:\\ 0\\.010896152218319485\ \(0\)\
\-\ been\\:\\ 0\\.010567249497563595\ \(0\)\
\-\ if\\:\\ 0\\.01053974288082107\ \(0\)\
\-\ significant\\:\\ 0\\.010444759777519196\ \(0\)\
\-\ is\\:\\ 0\\.010223468697904102\ \(0\)\
\-\ \\,\\:\\ 0\\.009844002382446813\ \(0\)\
\-\ symptoms\\:\\ 0\\.009680261258627905\ \(0\)\
\-\ 1\\:\\ 0\\.00924239258163503\ \(0\)\
\-\ noted\\:\\ 0\\.00920645994751179\ \(0\)\
\-\ associated\\:\\ 0\\.00916573891776228\ \(0\)\
\-\ most\\:\\ 0\\.008967432462400345\ \(0\)\
\-\ other\\:\\ 0\\.00895290249410204\ \(0\)\
\-\ diagnosis\\:\\ 0\\.008919178776274635\ \(0\)\
\-\ this\\:\\ 0\\.008737611030128482\ \(0\)\
\-\ case\\:\\ 0\\.008497747422123957\ \(0\)\
\-\ 2\\:\\ 0\\.00836411134777521\ \(0\)\
\-\ but\\:\\ 0\\.008284105913788807\ \(0\)\
\-\ treatment\\:\\ 0\\.007861895270913122\ \(0\)\
\-\ also\\:\\ 0\\.0076573617894097785\ \(0\)\
\-\ male\\:\\ 0\\.0070236615358521505\ \(0\)\
\-\ for\\:\\ 0\\.006628255896751955\ \(0\)\
\-\ by\\:\\ 0\\.0064675950147494304\ \(0\)\
\-\ be\\:\\ 0\\.005989803287926951\ \(0\)\
\-\ as\\:\\ 0\\.005875352299518763\ \(0\)\
\-\ a\\:\\ 0\\.005408179115708199\ \(0\)\
\-\ \\:\\:\\ 0\\.005137612799957568\ \(0\)\
\-\ was\\:\\ 0\\.004492170555516758\ \(0\)\
\-\ right\\:\\ 0\\.004098325950501894\ \(0\)\
\-\ \\.\\:\\ 0\\.004034038192880258\ \(0\)\
\-\ patient\\:\\ 0\\.0038935996859835813\ \(0\)\
\-\ with\\:\\ 0\\.003722860148314673\ \(0\)\
\-\ on\\:\\ 0\\.0032904136925701274\ \(0\)\
\-\ \\(\\:\\ 0\\.0032834623920175478\ \(0\)\
\-\ \\)\\:\\ 0\\.0032433531459695685\ \(0\)\
\-\ the\\:\\ 0\\.002513623358247742\ \(0\)\
\-\ of\\:\\ 0\\.0021182509235997894\ \(0\)\
\-\ to\\:\\ 0\\.0019412186747408465\ \(0\)\
